Navigation Links
Vermillion Files Amended Plan of Reorganization and Exchanges Debt
Date:12/4/2009

FREMONT, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement with the United States Bankruptcy Court for the District of Delaware.

A hearing to consider the adequacy of the Disclosure Statement is presently scheduled for December 8, 2009, with the hearing on the confirmation of the Plan scheduled for January 7, 2010.

"We are pleased to report that we have continued cooperation from our stakeholders on the restructuring," said Gail Page, Vermillion Executive Chairperson. "We have also made significant progress improving our balance sheet by equitizing most of our convertible debt. The principal balance of our 7% Senior Convertible Notes due 2011 has now been reduced to $5 million."

Subject to approval of the creditors and the bankruptcy court, the Company is poised to emerge from Chapter 11 in early January 2010.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at www.vermillion.com.

About the OVA1 Test

The OVA1 Test is a qualitative serum test that combines the results of five immunoassays into a single numerical score. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. The test utilizes fi
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vermillion Files Plan of Reorganization
2. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
3. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
6. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
7. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
8. Vermillion Receives Award From the Society of Gynecologic Oncologists
9. Watson Files FDA Application for Generic Rozerem(R)
10. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
11. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Yesterday, former Congressman Patrick Kennedy ... facility. Rep. Kennedy and Dick Moberg ... research in neurological disease and treatment. ... Garen Staglin , created One Mind, a ... that will radically accelerate the development and implementation ...
(Date:7/10/2014)... TUCSON, Ariz. , July 10, 2014   ... Roche  Group, today announced it has entered into an ... , which operates as EMD Serono in ... , to collaborate with Merck KGaA,s biopharmaceutical division ... (CDx) for an undisclosed target using Ventana,s proprietary diagnostic ...
(Date:7/10/2014)... 10, 2014 CVS Caremark Corporation (NYSE: ... approved a quarterly dividend of $0.275 (27.5 cents) per share ... August 1, 2014, to holders of record on July 21, ... Caremark is dedicated to helping people on their path to ... the United States . Through the company,s more ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... , ALLEGAN, Mich. , Jan. 27 ... Directors declared a quarterly dividend of $0.0625 per ... of record on February 26, 2010 . , Perrigo ... and distributes over-the-counter (OTC) and generic prescription pharmaceuticals, nutritional products, ...
... , NEW YORK , Jan. ... Investments, Inc. (NYSE Amex: MGT ), and an industry ... analysis software which assists radiologists in the early detection of ... received a further request for Additional Information (AI) letter from ...
Cached Medicine Technology:Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance 2Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance 3
(Date:7/12/2014)... Demand Response Management Systems is a crucial peak ... imbalance between energy supply and demand. With the help ... (due to increasing pressure on the grid) and replaced ... residential appliances and thermostats for load reduction. , ... and with government mandates and benefits for energy efficiency ...
(Date:7/12/2014)... 12, 2014 Tylenol lawsuits ( ... move forward in the federal multidistrict litigation underway ... Bernstein Liebhard LLP reports. According to a filing ... F. Stengel has ordered the deposition of a ... found that the witness’s testimony concerning the marketing ...
(Date:7/12/2014)... (HealthDay News) -- Burn injuries increase in the summer as ... burn experts. Among those most vulnerable to these seasonal fire ... and often get burned by putting their hands on the ... the burn unit at Loyola University Medical Center in Maywood, ... adage of ,When you play with fire, you get burned, ...
(Date:7/12/2014)... July 12, 2014 “After my mom’s stroke, she ... a stroke and loss the use of his left side. Eating ... a way to help people like them enjoy eating again,” said ... prototype for the PATRICIA CAROL HALL PLATE (P C H PLATE). ... a more ergonomic way to eat for individuals who suffer from ...
(Date:7/12/2014)... July 12, 2014 With prom shopping ... manufacturer and retailer, is ready to showcase its new ... new collection of evening dresses in its online shop. ... 67% off) for these elegant gowns. According to the ... end on July 26, 2014. , He says, ...
Breaking Medicine News(10 mins):Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2
... clinical trial of the experimental drug dimebon (latrepirdine) in people ... cognition. That is the conclusion of a study published ... "This is the first clinical trial that has focused ... disease," said University of Rochester Medical Center neurologist Karl Kieburtz, ...
... with use, but other factors may contribute, experts say , ... treat glaucoma appear to outlive those who don,t treat the ... reduced risk for premature death stems from the glaucoma drugs ... access to health care remains unclear. , Use of glaucoma ...
... residue may give rise to new pollutants indoors, chemists ... smoke residue found on indoor surfaces -- so-called "third-hand ... new, potentially cancer-causing substances, research suggests. , Details about ... what health concerns it might create remain unclear, however, ...
... BOSTON , Feb. 8 The National Patient ... on March 7, 2010 , in a concerted effort ... of health care, and strengthen alliances between patients, families and ... During the week, participating hospitals and healthcare systems will plan ...
... , Feb. 8 Independence Blue Cross (IBC) today ... newly created role of senior vice president of marketing services. He ... executive, Linda M. Taylor . , In this new ... care consumers better manage their care and will also head product ...
... , Feb. 8 SpectraCell Laboratories announced that ... D.C. to its scientific staff as Director of Clinical Nutrition ... national basis and consult with clients on the implementation of ... is a long-time client of SpectraCell, using their micronutrient testing ...
Cached Medicine News:Health News:Drug shows promise for Huntington's disease 2Health News:Glaucoma Drugs May Play Role in Longer Life 2Health News:Glaucoma Drugs May Play Role in Longer Life 3Health News:'Third-Hand Smoke' Could Be Troublesome, Too 2Health News:'Third-Hand Smoke' Could Be Troublesome, Too 3Health News:National Patient Safety Foundation Leads Nationwide Effort to Promote Patient Safety 2Health News:Independence Blue Cross Names John Janney to Newly Created Position: Senior Vice President Marketing Services 2Health News:Independence Blue Cross Names John Janney to Newly Created Position: Senior Vice President Marketing Services 3Health News:Dr. Ron Grabowski Named Director of Clinical Nutrition and Education for SpectraCell Laboratories 2Health News:Dr. Ron Grabowski Named Director of Clinical Nutrition and Education for SpectraCell Laboratories 3
InterVascular HemaPatch product line offers the vascular surgeon a range of collagen coated patches in a range of larger sizes angioplasty, or profundaplasty procedures without suture hole bleeding. ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
D-Stat Radial is a dry version of the D-Stat together with a compression band, and is designed for the control of surface bleeding from vascular access sites, including the sites on the radial artery...
The D-Stat Radial hemostat band utilizes a compression band together with the active haemostatic material of the D-Stat to control surface bleeding....
Medicine Products: